These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tenofovir-associated renal and bone toxicity. Woodward CL; Hall AM; Williams IG; Madge S; Copas A; Nair D; Edwards SG; Johnson MA; Connolly JO HIV Med; 2009 Sep; 10(8):482-7. PubMed ID: 19459988 [TBL] [Abstract][Full Text] [Related]
3. Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature. Haverkort ME; van der Spek BW; Lips P; Slieker WA; ter Heine R; Huitema AD; Bronsveld W Scand J Infect Dis; 2011 Oct; 43(10):821-6. PubMed ID: 21563880 [TBL] [Abstract][Full Text] [Related]
4. Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV. Lucey JM; Hsu P; Ziegler JB BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843401 [TBL] [Abstract][Full Text] [Related]
5. Recurrent bone fractures due to tenofovir-induced renal phosphate wasting. Koenig KF; Kalbermatter S; Menter T; Graber P; Kiss D Scand J Infect Dis; 2014 Mar; 46(3):221-4. PubMed ID: 24147545 [TBL] [Abstract][Full Text] [Related]
7. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. Cooper RD; Wiebe N; Smith N; Keiser P; Naicker S; Tonelli M Clin Infect Dis; 2010 Sep; 51(5):496-505. PubMed ID: 20673002 [TBL] [Abstract][Full Text] [Related]
8. Serum hypophosphatemia in tenofovir disoproxil fumarate recipients is multifactorial in origin, questioning the utility of its monitoring in clinical practice. Day SL; Leake Date HA; Bannister A; Hankins M; Fisher M J Acquir Immune Defic Syndr; 2005 Mar; 38(3):301-4. PubMed ID: 15735448 [TBL] [Abstract][Full Text] [Related]
9. Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman. Kiyasu Y; Koganemaru H; Hitomi S J Infect Chemother; 2012 Apr; 18(2):255-7. PubMed ID: 21918819 [TBL] [Abstract][Full Text] [Related]
10. Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate. Gatanaga H; Tachikawa N; Kikuchi Y; Teruya K; Genka I; Honda M; Tanuma J; Yazaki H; Ueda A; Kimura S; Oka S AIDS Res Hum Retroviruses; 2006 Aug; 22(8):744-8. PubMed ID: 16910829 [TBL] [Abstract][Full Text] [Related]
11. Normal plasma FGF23 levels kinetic in tenofovir-related hypophosphatemic osteomalacia in an HIV-infected patient with von Recklinghausen disease. Saidenberg-Kermanac'h N; Souabni L; Prendki V; Prie D; Boissier MC Joint Bone Spine; 2011 May; 78(3):306-8. PubMed ID: 21185214 [TBL] [Abstract][Full Text] [Related]
12. Fanconi syndrome accompanied by renal function decline with tenofovir disoproxil fumarate: a prospective, case-control study of predictors and resolution in HIV-infected patients. Gupta SK; Anderson AM; Ebrahimi R; Fralich T; Graham H; Scharen-Guivel V; Flaherty JF; Fortin C; Kalayjian RC; Rachlis A; Wyatt CM PLoS One; 2014; 9(3):e92717. PubMed ID: 24651857 [TBL] [Abstract][Full Text] [Related]
13. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir. Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504 [TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study. Woratanarat K; Kanjanabuch T; Suankratay C J Med Assoc Thai; 2013 Apr; 96(4):432-9. PubMed ID: 23691697 [TBL] [Abstract][Full Text] [Related]